Free Trial

Kalaris Therapeutics (KLRS) Institutional Ownership

Kalaris Therapeutics logo
$4.92 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$5.10 +0.18 (+3.56%)
As of 05/22/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kalaris Therapeutics (NASDAQ:KLRS)

Current
Institutional Ownership
Percentage
66.05%
Number of
Institutional Buyers
(last 12 months)
29
Total
Institutional Inflows
(last 12 months)
$33.38M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$2.17M
Get KLRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kalaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KLRS Institutional Buying and Selling by Quarter

Kalaris Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2026 Kalehua Capital Management LLC135,585$782K0.6%-3.1%0.570%
5/14/2026 Renaissance Technologies LLC66,151$382K0.0%-24.6%0.288%
5/7/2026 WealthTrust Asset Management LLC12,416$72K0.0%N/A0.054%
4/27/2026 Simplify Asset Management Inc.87,426$504K0.0%+335.5%0.381%
2/18/2026 XTX Topco Ltd10,897$92K0.0%N/A0.058%
2/18/2026 Ikarian Capital LLC360,000$3.04M0.2%N/A1.925%
2/18/2026 RTW Investments LP1,300,000$10.97M0.1%N/A6.952%
2/18/2026 Boothbay Fund Management LLC92,261$779K0.0%N/A0.493%
2/18/2026 683 Capital Management LLC80,590$680K0.0%N/A0.431%
2/17/2026 ADAR1 Capital Management LLC100,000$844K0.1%N/A0.535%
2/17/2026 Paradigm Biocapital Advisors LP700,000$5.91M0.2%N/A3.743%
2/16/2026 Squarepoint Ops LLC25,367$214K0.0%-36.9%0.136%
2/16/2026 OMERS ADMINISTRATION Corp30,000$253K0.0%N/A0.160%
2/16/2026 Barclays PLC6,065$51K0.0%N/A0.032%
2/13/2026 Marshall Wace LLP72,876$615K0.0%+416.3%0.390%
2/13/2026 Walleye Capital LLC11,225$95K0.0%N/A0.060%
2/13/2026 Kalehua Capital Management LLC139,901$1.18M1.1%N/A0.748%
2/13/2026 Alyeska Investment Group L.P.403,551$3.40M0.0%N/A2.158%
2/13/2026 Siren L.L.C.435,798$3.68M0.1%+36.9%2.330%
2/13/2026 State Street Corp25,410$214K0.0%+12.4%0.136%
2/12/2026 Jane Street Group LLC33,114$279K0.0%N/A0.177%
2/12/2026 Renaissance Technologies LLC87,751$741K0.0%-22.2%0.469%
2/12/2026Keel Point LLC10,225$86K0.0%N/A0.055%
2/11/2026 Propel Bio Management LLC42,053$355K0.3%N/A0.225%
2/10/2026 Goldman Sachs Group Inc.34,303$290K0.0%+52.7%0.183%
2/9/2026 Geode Capital Management LLC82,647$698K0.0%+28.0%0.442%
2/9/2026 Simplify Asset Management Inc.20,074$169K0.0%N/A0.107%
2/6/2026 Nano Cap New Millennium Growth Fund L P4,000$34K0.0%N/A0.021%
2/5/2026 WHI TRUST Co LLC97,493$823K0.6%N/A0.521%
11/17/2025 Woodline Partners LP241,102$1.39M0.0%N/A1.289%
11/17/2025 Millennium Management LLC24,923$144K0.0%-53.9%0.133%
11/14/2025 Bridgeway Capital Management LLC22,500$130K0.0%N/A0.120%
11/14/2025 Squarepoint Ops LLC40,173$232K0.0%-32.0%0.215%
11/13/2025 Johnson Financial Group Inc.10,000$58K0.0%N/A0.053%
11/3/2025 Belpointe Asset Management LLC40,000$231K0.0%N/A0.214%
10/31/2025 Fortis Capital Advisors LLC40,000$231K0.0%N/A0.214%
8/15/2025 Octagon Capital Advisors LP360,000$961K0.2%-25.2%1.925%
8/14/2025 Gilead Sciences Inc.317,789$848K0.1%-56.1%1.699%
8/12/2025 XTX Topco Ltd24,234$65K0.0%N/A0.130%


KLRS Institutional Ownership - Frequently Asked Questions

During the previous two years, 34 institutional investors and hedge funds held shares of Kalaris Therapeutics. The most heavily invested institutionals were RTW Investments LP ($10.97M), Paradigm Biocapital Advisors LP ($5.91M), Siren L.L.C. ($3.68M), Alyeska Investment Group L.P. ($3.40M), Ikarian Capital LLC ($3.04M), Woodline Partners LP ($1.39M), and Octagon Capital Advisors LP ($961K).Learn more on Kalaris Therapeutics' institutional investors.

66.05% of Kalaris Therapeutics' stock is owned by institutional investors. Learn more on KLRS's institutional investor holdings.

Of the 29 institutional investors that purchased Kalaris Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($1.30M), Paradigm Biocapital Advisors LP ($700K), Alyeska Investment Group L.P. ($403.55K), Ikarian Capital LLC ($360K), Woodline Partners LP ($241.10K), Kalehua Capital Management LLC ($139.90K), and Siren L.L.C. ($117.53K).

Institutional investors have bought a total of 4,108,082 shares in the last 24 months. This purchase volume represents approximately $33.38M in transactions.

The following institutional investors have sold Kalaris Therapeutics stock in the last 24 months: Gilead Sciences Inc. ($405.48K), Octagon Capital Advisors LP ($121K), Renaissance Technologies LLC ($46.60K), Squarepoint Ops LLC ($33.73K), Millennium Management LLC ($29.17K), and Kalehua Capital Management LLC ($4.32K).

Institutional investors have sold a total of 640,297 shares in the last 24 months. This volume of shares sold represents approximately $2.17M in transactions.



This page (NASDAQ:KLRS) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners